Stock listing

Atossa Therapeutics, Inc.

Selected listing: A2JJ99 · LS · EUR · DE

Atossa Therapeutics, Inc. (Lang & Schwarz: A2JJ99), Health Technology. Latest release Sep 29, 2026: Atossa Therapeutics Announces Plan to Issue Stapled CVR…

A2JJ99:LSEURDEUpdated October 2, 2026

Ticker: Lang & Schwarz: A2JJ99
Asset type: Stock
Sector: Health Technology
Industry: Pharmaceuticals: Major
Exchange: Lang & Schwarz
Currency: EUR

Latest news from Atossa Therapeutics, Inc.

Atossa Therapeutics Announces Plan to Issue Stapled CVR for Shareholders Tied to Potential Rare Pediatric Disease Priority Review Voucher

September 29, 2026

Atossa Therapeutics Announces Publication of Novel (Z)-Endoxifen-Related Compounds Demonstrating Potent Anti-Cancer Activity in ER-Positive Breast Cancer

July 28, 2026

Atossa Therapeutics Announces Presentation of Mechanism-Driven (Z)-Endoxifen Data in McCune-Albright Syndrome at AACR Special Conference on Rare Cancers

July 21, 2026

Atossa Therapeutics Announces Closing of Registered Direct Offering of up to $16.5 Million in Gross Proceeds

June 12, 2026

Atossa Therapeutics Announces Registered Direct Offering of up to $16.5 Million in Gross Proceeds

June 11, 2026

All Atossa Therapeutics, Inc. news →

Events

Replays

Atossa Therapeutics, Inc. (ATOS) Q4 2024 Earnings Call
Tue, Mar 25, 2025 · 08:30 AM ET
Watch
Atossa Therapeutics, Inc. (ATOS) Q4 2023 Earnings Call
Tue, Mar 26, 2024 · 09:00 AM ET
Watch
Atossa Therapeutics, Inc. (ATOS) Q3 2023 Earnings Call
Thu, Oct 26, 2023 · 09:00 AM ET
Watch

Research Atossa Therapeutics, Inc.

Atossa Therapeutics, Inc. company profile

View the public company page for Atossa Therapeutics, Inc. on 6ix.

Atossa Therapeutics, Inc. news

Read company news and market updates connected to Atossa Therapeutics, Inc..

Atossa Therapeutics, Inc. investor events

Find investor webinars, events, and replay context for Atossa Therapeutics, Inc..